MB-6 / Microbio - LARVOL DELTA

A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer. (clinicaltrials.gov) - P=N/A; N=184; Recruiting; Sponsor: Microbio Co Ltd; Trial completion date: Mar 2019 ➔ Dec 2022; Trial primary completion date: Dec 2018 ➔ Mar 2022

Clinical • Trial completion date • Trial primary completion date • Colorectal Adenocarcinoma • Colorectal Cancer • Gastrointestinal Cancer • Hematological Disorders • Neutropenia • Oncology • Solid Tumor